Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Page 103

Category: BiotechToday

News

  • BiotechToday
  • World

DENMARK TO KILL UPTO 17 MILLION MINKS!

bioxone November 8, 2020November 7, 2020 1

Aakancha Shaw, St. Xavier’s College, Kolkata Minks are dark-coloured and carnivorous mammals. Denmark has always been Europe’s largest producer and exporter of mink furs. So, Why is Denmark planning to kill its mink population? Recently, about 214 human COVID-19 cases in Denmark are related to minks. A mink-variant mutation in the spike protein of the […]

Read More
  • BiotechToday
  • World

SAlign – A System to connect global PPI network alignment

bioxone November 8, 2020November 7, 2020

SHRESTHA DUTTA, AMITY UNIVERSITY KOLKATA Proteins are enormous biomolecules that carry out their work by interacting with different biomolecules. In recent times, the quantity of protein interaction information has been augmented significantly because of the advancement in high throughput tests. PPI systems of two species can be contrasted to identify evolutionary preserved interactions. It can […]

Read More
  • BiotechToday
  • World

MIP- a way for selective recognition of microorganisms

bioxone November 7, 2020November 7, 2020 1

Ayooshi Mitra, Amity University Kolkata Molecularly imprinted polymers, also known as MIPs, were first developed about half a century ago. It uses the technique of molecular imprinting that leaves cavities with an affinity for a selected “template” molecule within the polymer matrix. In the presence of a template molecule that is extracted afterwards, the process […]

Read More
  • BiotechToday
  • India

India set to begin the COVID-19 vaccination soon

bioxone November 7, 2020November 7, 2020 1

Prama Ghosh, Amity University Kolkata India is preparing to roll out COVID-19 vaccines with Anganwadi centres, schools, panchayat buildings and other such setups and buildings identified by the state governments as vaccination sites in addition to healthcare facilities. The anti-corona virus inoculation drive would be monitored by the Union health ministry’s digital platform and tracking […]

Read More
  • BiotechToday
  • World

Chloroquine, Hydroxychloroquine hurts COVID-19 patients with Cardiac Disease

bioxone November 7, 2020November 7, 2020 1

Devyani Goswami, Amity University Kolkata  Right after in the early months of the pandemic the US government has asked for a huge supply of hydroxychloroquine from the Indian government as the primary drug to be used in the treatment of SARS-CoV-19. Though after a few months both hydroxychloroquine and chloroquine were considered to be an […]

Read More
  • BiotechToday
  • World

Gene therapy clinical trials for rare Angelman syndrome put on hold

bioxone November 7, 2020November 6, 2020 1

Surupa Chakraborty, Amity University Kolkata A new gene therapy clinical trial for treating Angelman syndrome has been put to hold after two candidates temporarily lost their ability to walk. GTX102, the drug used in the clinical trial was developed by a California-based biopharmaceutical company Ultragenyx, in collaboration with GeneTx, a Florida-based biotech startup. The trial […]

Read More
  • BiotechToday
  • World

Protrudin supports axon regeneration in the adult CNS

bioxone November 6, 2020November 6, 2020

Saptaparna Pal, Amity University Kolkata Axons of the adult peripheral nervous system(PNS) and immature central nervous system (CNS) neurons readily regenerate after injury. In addition to the non-permissive extracellular environment after injury, the intrinsic neuronal factors also play an important role in the regenerative failure that is observed in mature CNS neurons. Protrudin acts as […]

Read More
  • BiotechToday
  • World

LINKAGE BETWEEN HGI AND FAMILY BACKGROUND OF HYPERTENSION

bioxone November 6, 2020November 6, 2020 2

Aishila Kar, Amity University Kolkata Hypertension, along with difficulties like stroke and chronic kidney disease, consumes social and medical wealth. Around 43% of cardiovascular incidents were found to be assigned to hypertension. Haemoglobin glycation index (HGI) is observed to be a convenient measurable indicator to evaluate the individual difference of HbA1c. In the current study, […]

Read More
  • BiotechToday
  • World

Mantis- A high-quality protein function annotation tool

bioxone November 6, 2020November 5, 2020

Prama Ghosh, Amity University Kolkata There has been a rapid development in the field of meta-omics in the past decade thereby producing an unprecedented amount of data. Methods such as Next Generation Sequencing produce a large amount of data that needs to be interpreted to understand the role of previously functionally unannotated proteins of an […]

Read More
  • BiotechToday
  • World

Can synthetic antibodies combat Covid-19?

bioxone November 6, 2020November 5, 2020 1

Husna, Amity University Kolkata The SARS-CoV-2 virus can infect a cell by the interaction between the viral spike protein and the human cell surface protein ACE2. It binds with ACE2 using receptor-binding domains (RBDs) which are finger-like protrusions. Therefore, by blocking these receptors, the viral entry into human cells can be stopped and this can be […]

Read More

Posts navigation

1 … 99 100 101 102 103 104 105 106 107 … 137

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy